HYTN Awarded Drug Establishment License from Health Canada, Able to Export Cannabis Pharmaceutical Products Globally

2 years ago

HYTN Innovations Inc., a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, announces that it has been granted a Drug Establishment License (DEL) by Health Canada. [PRESS RELEASE] VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or […]